Study Finds Distinct DNA Methylation Patterns in PTSD Brains

Researchers analyzed 302 donated postmortem brains to compare epigenetic markers across PTSD, depression and healthy controls.

Updated on Nov. 20, 2026 in Mental Health

A clear glass vessel of pale amber liquid sits on a bare steel laboratory bench under soft overhead daylight, with a blurred cool-toned lab interior behind it.
Researchers analyzing 302 donated postmortem brains reported distinct DNA methylation patterns in PTSD compared with healthy controls and major depressive disorder, published in Cell Reports on November 20, 2026. AI Illustration. Upload story photo >

Researchers identified DNA methylation differences in postmortem brains of people with PTSD that differ from those without disorders and from those with major depressive disorder. The study, published in Cell Reports on November 20, 2026, examined the prefrontal cortex, amygdala and hippocampus.

Why it matters

The findings suggest PTSD and major depressive disorder leave different epigenetic signatures in the brain, which could eventually support more precise diagnosis. Blood tests based on these markers could potentially help guide PTSD diagnosis and treatment in the future.

The analysis covered 302 donated postmortem brains, including 101 from people with PTSD, 101 with major depressive disorder and 100 without diagnosed psychiatric disorders as controls. Whether these methylation patterns hold up with sex, trauma timing and substance use taken into account has not yet been determined.

The players

Cell Reports

Cell Reports is a peer-reviewed open-access scientific journal published by Cell Press that covers biology across many disciplines.

University of Texas at Austin

The University of Texas at Austin is a public research university whose researchers, including co-author Frances Champagne, contributed to the study.

Emory University School of Medicine

Emory University School of Medicine is a leading medical school in Atlanta, Georgia, whose investigators commented on the research without being involved in it.

The details

The researchers measured DNA methylation in postmortem brain tissue across the prefrontal cortex, amygdala and hippocampus. In PTSD brains, methylation patterns differed from controls in the prefrontal cortex, while depression showed distinct methylation in the amygdala and affected the same set of genes across brain regions, unlike the inconsistent gene sets seen in PTSD.

Timeline

  1. November 20, 2026: Study published in the journal Cell Reports.

Big Picture

The study extends postmortem epigenetic research on psychiatric disorders by comparing PTSD and major depressive disorder side by side within the same brain regions. Its contrast between PTSD's inconsistent gene sets and depression's consistent ones points toward separating the two conditions at the molecular level.

If blood-based tests are developed from these markers, people with PTSD could eventually have a biological test to support diagnosis alongside clinical evaluation. Such tests would still need validation before they could change how treatment is chosen.

The takeaway

Psychiatric conditions like PTSD and depression appear to leave distinct molecular traces in the brain, which may eventually improve how they are told apart. Readers should view these early findings as a foundation for future research rather than a ready clinical test.

What happens next

The research team plans to investigate how factors such as sex, timing of trauma and substance use history affect the methylation patterns it identified.

Further reading

Explore more research on Mental Health to see how scientists are studying these conditions.

More information

Read the full Cell Reports study on PTSD brain methylation in the journal's published record.